Market Cap

Moderna, Inc. Market Capitalization:

$41.43 Billion

USD as of Jan. 1, 2024

business Moderna, Inc. Company Profile

Moderna, Inc. Main Stock Listing

NASDAQ: MRNA

Market Capitalization History of Moderna, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Moderna, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $41.43 B -39.45%
Jan. 1, 2023 $68.42 B 4.85%
Jan. 1, 2022 $65.25 B -2.21%
Jan. 1, 2021 $66.73 B 744.27%
Jan. 1, 2020 $7.90 B 23.55%
Jan. 1, 2019 $6.40 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Company Description

Moderna, Inc. is a biotechnology company, specialized in vaccine technology based on messenger RNA. It is notably famous for producing one of the first vaccines against Covid-19, and it is also developing and patenting other vaccine candidates for seasonal flu, HIV, the Nipah virus, and a second COVID-19 vaccine.

business Moderna, Inc. Company Profile

Stocks & Indices

Moderna, Inc. has the following listings and related stock indices.


Stock: NASDAQ: MRNA

Stock: BMV: MRNA

Stock: Bovespa: M1RN34

Stock: FSX: 0QF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.